These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3777954)

  • 1. [Combination of radiotherapy with cisplatin in esophageal cancer].
    Tohnosu N; Onoda S; Okuyama K; Yamamoto Y; Kimura M; Awano T; Tsukamoto S; Isono K; Ishikawa T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3169-74. PubMed ID: 3777954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
    Iwase H
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].
    Jiang YY; Wu SX; Zhang P; Xie CY; Wang J; Sun CC
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2171-4. PubMed ID: 19080664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
    Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of cisplatin in concurrent use with radiotherapy in esophageal carcinoma--joint research among nationwide multi-facilities, primary results. Research Committee for Radiation and Cisplatin Treatment of Esophageal Carcinoma].
    Ishikawa T; Irie G; Asakawa H; Ikeda M; Dokiya T; Morita K; Inoue T; Masuda K
    Gan No Rinsho; 1990 Jan; 36(1):1-6. PubMed ID: 2405207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy.
    Shimoyama S; Aoki F; Kojima J; Kaminishi M
    Hepatogastroenterology; 1999; 46(28):2409-13. PubMed ID: 10522007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy for resectable oesophageal cancer: results of a pilot study.
    Gignoux M; Bosset JF
    Anticancer Res; 1989; 9(4):1023-4. PubMed ID: 2817783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].
    Bedenne L; Seitz JF; Milan C; Renard P; Fraisse J; Conroy T; Lacourt J; Janoray P; Faivre J
    Gastroenterol Clin Biol; 1998 Mar; 22(3):273-81. PubMed ID: 9762210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer.
    Morita M; Kuwano H; Ohno S; Kitamura K; Sugimachi K
    Anticancer Res; 2000; 20(5C):3631-6. PubMed ID: 11268430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus.
    Kumar S; Dimri K; Khurana R; Rastogi N; Das KJ; Lal P
    Radiother Oncol; 2007 May; 83(2):139-47. PubMed ID: 17445928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.
    Poplin EA; Jacobson J; Herskovic A; Panella TJ; Valdivieso M; Hutchins LF; Macdonald JS
    Cancer; 1996 Nov; 78(9):1851-6. PubMed ID: 8909302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary clinical evaluation of continuous infusion of 5-FU and low-dose Cisplatin (LFP) therapy alone and combined with radiation therapy for treatment of advanced or recurrent esophageal cancer].
    Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):233-8. PubMed ID: 11865629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.